APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 17 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $95,989,624 | +20.8% | 51,793,000 | -0.2% | 2.14% | +30.2% |
| Q4 2022 | $79,433,341 | -19.9% | 51,885,000 | 0.0% | 1.64% | -16.7% |
| Q3 2022 | $99,115,000 | +29.6% | 51,885,000 | 0.0% | 1.97% | +25.1% |
| Q2 2022 | $76,456,000 | -6.4% | 51,885,000 | 0.0% | 1.58% | -13.7% |
| Q1 2022 | $81,724,000 | +87.7% | 51,885,000 | +80.0% | 1.83% | +100.1% |
| Q4 2021 | $43,542,000 | +22.7% | 28,825,000 | 0.0% | 0.91% | +31.7% |
| Q3 2021 | $35,498,000 | -54.4% | 28,825,000 | -31.1% | 0.69% | -49.8% |
| Q2 2021 | $77,769,000 | +154.4% | 41,825,000 | +91.6% | 1.38% | +114.8% |
| Q1 2021 | $30,574,000 | -66.9% | 21,825,000 | -60.2% | 0.64% | -64.8% |
| Q4 2020 | $92,483,000 | +32.6% | 54,825,000 | -15.4% | 1.83% | +7.7% |
| Q3 2020 | $69,727,000 | – | 64,825,000 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 15,000,000 | $35,954,355 | 1.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $28,207,024 | 0.34% |
| LINDEN ADVISORS LP | 10,000,000 | $23,952,985 | 0.25% |
| Verition Fund Management LLC | 4,796 | $11,487,633 | 0.15% |
| LORD, ABBETT & CO. LLC | 11,712,000 | $28,044 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,267,000 | $3,044,070 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 14,242,000 | $34,113 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $717,076 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $11,995,383 | 0.01% |
| Citadel Advisors | 11,500,000 | $27,556,934 | 0.01% |